The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.

What about the side-effects? Will I regain all my weight? Dr Sarah Jarvis has the answers to your burning questions.

With rumours circulating that Selena Gomez and other celebrities have used Ozempic, we reached out to experts to understand ...

A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...

AbbVie is entering the obesity treatment market with a $2.3bn licensing agreement to acquire global rights to GUB014295, a ...

For Oscars 2025, there's a new trend in town: microdosing, taking tiny amounts of Ozempic and other weight-loss jabs is the ...

AbbVie inked a licensing deal Monday worth up to $2.23 billion for an amylin-targeting obesity treatment from Denmark-based ...

GUB014295 is a subcutaneously administered long-acting amylin agonist that also stimulates calcitonin receptors, according to ...

As a leading nutrition and longevity expert, I often see patients who want my advice on whether they should start taking ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...